Correction: Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: Retrospective analyses of two phase II randomised Spanish TTD trials (ESMO Open (2019) 4 (e000599) DOI: 10.1136/esmoopen-2019-000599
- Benavides, M.
- Díaz-Rubio, E.
- Carrato, null
Zeitschrift:
ESMO Open
ISSN: 2059-7029
Datum der Publikation: 2020
Ausgabe: 5
Nummer: 1
Art: Erratum